Tag: India

Indian pharmaceutical companies intend to enter the Russian market

Indian companies, including Advance Pharma, Hetero Labs, and Sun Pharma, intend to enter the Russian pharmaceutical market, said Shubham Kumar, the Consul General of India in Vladivostok.

Indian pharma company is looking for a construction site in Ingushetia

india pharma
Gogineni Vijayakumar, General Director of Varthamana International Traders has arrived in the Republic of Ingushetia. The Chairman of the Government of the Republic of Ingushetia held a working meeting.

China will conduct regulatory trainings for Indian pharma companies

china street
China has agreed to conduct specific training programmes for Indian pharmaceutical companies to understand their regulatory system, which will promote India's exports from the sector.

The Indian government will set a new drug policy and rules for clinical trials

A team of Indian officials led by Dr. G N Singh, Drug Controller General of India, informed that a set of new procedures to facilitate clinical trials are expected to be unveiled shortly.

Omnicare Drugs India and ASKA Pharmaceuticals set up a joint venture

Omnicare Drugs India, an arm of the UAE-based Neopharma LLC, and Japan’s ASKA Pharmaceuticals have inked an agreement to establish a joint venture (JV) in India.

India aims to stimulate local API manufacturing

india pharma
In a bid to reduce India’s dependence on China for active pharmaceutical ingredients, the chemicals and fertilizers Indian ministry has joined hands with other ministries to draw up a road map for increasing their production.

AstraZeneca will invest $90 million in India during the next five years

Leading global science-led biopharmaceutical company AstraZeneca announced its decision of further investing $90 million over the next 5 years in India.

Indian scientists developed an Ayurvedic dengue drug

The Central Council for Research in Ayurvedic Sciences (CCRAS, India) and regional research centre in Karnataka’s Belgaum (India) have started conducting pilot studies for the medicine that have been proved clinically safe.

The Government of India submitted a draft amendment on cell therapies

stem cells
The Ministry of Health and Family Welfare of India, after consultations with the Drugs Technical Advisory Board (DTAB), has proposed a draft amendment that defines stem cell-based products (SCBP).

Indian Immunologicals launches a pentavalent vaccine

Developed with the company’s research and development expertise, it will be made at the IIL’s vaccine manufacturing facility in Hyderabad for retail market as well as the national Universal Immunisation Programme.

India increased its pharmaceutical exports to Russia by 19% for over one year

india pharma
According to the Russian Federal Customs Service, in 2017, the exports of pharmaceutical products from India to Russia reached 560 million dollars, while the total weight of exports amounted to 14 thousand tons.

Construction of JivaPharm plant will be completed before the end of 2018

The construction of JivaPharm plant for the joint venture between Belarus and India in Kolyadichi is scheduled for completion by the end of 2018

Pfizer and ICMR will create an antimicrobial resistance centre in India

antimicrobial resistance
The Indian Council of Medical Research and Pfizer have announced a partnership to set up a centre aimed at combating growing Antimicrobial Resistance in India.

WHO provided prequalification for the world’s first rotavirus vaccine

Bharat Biotech, an Indian biopharmaceutical company, announced that the World Health Organization has awarded prequalification to the developing world’s first rotavirus vaccine, ROTAVAC

Panacea Biotech signs an important deal with Serum Institute of India

Panacea Biotech Ltd., India's leading biopharmaceutical company and the largest manufacturer of vaccines, has signed two long-term collaboration agreements with Serum Institute of India

CPhI Global Pharma Index: India’s reputation improving and ranks third most competitive nation

India reputation findings released as CPhI & P-MEC India set to welcome 50,000 pharma executives